» Articles » PMID: 34944871

MiR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Dec 24
PMID 34944871
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer (NKs) cells are cytotoxic effector cells, which can modulate tumor metastasis according to their function; however, the role of NK cells in lung cancer has not been extensively investigated. In this study, we determined the functional profiles of NK cells in a hypoxic tumor microenvironment (TME) of lung cancer. We revealed CD226 downregulation and functional repression of NK cells after hypoxic lung cancer priming and we then investigated their interaction with extracellular vesicles (EVs) and miR-150-5p. We also found that NK cells from lung cancer patients had lower expression of CD226 on their surface and exhibited a pro-inflammatory, pro-angiogenic and tumorigenesis phenotype by expressing VEGF, CXCL1, CXCL8, S100A8 and MMPs. Moreover, inhibition of miR-150 improved tumor surveillance by reversing CD226 expression and subsequently reinstating cytotoxic NK cell activity in an animal model. Our study introduces a new scenario for the pro-inflammatory and pro-angiogenic activities of NK cells in the hypoxic TME in lung cancer.

Citing Articles

MiR-150-5p inhibits cell proliferation and metastasis by targeting FTO in osteosarcoma.

Xu L, Zhang P, Zhang G, Shen Z, Bai X Oncol Res. 2024; 32(11):1777-1789.

PMID: 39449798 PMC: 11497191. DOI: 10.32604/or.2024.047704.


Recent advances to address challenges in extracellular vesicle-based applications for lung cancer.

Huang G, Zheng W, Zhou Y, Wan M, Hu T Acta Pharm Sin B. 2024; 14(9):3855-3875.

PMID: 39309489 PMC: 11413688. DOI: 10.1016/j.apsb.2024.06.010.


Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab.

Genova C, Marconi S, Chiorino G, Guana F, Ostano P, Santamaria S Clin Exp Med. 2024; 24(1):182.

PMID: 39105937 PMC: 11303437. DOI: 10.1007/s10238-024-01427-8.


A microRNA focus on acne.

Gordon S, Layton A, Fawcett S, Ross K Dermatol Reports. 2024; 16(2):9902.

PMID: 38957637 PMC: 11216150. DOI: 10.4081/dr.2024.9902.


The Clinical Significance and Involvement in Molecular Cancer Processes of Chemokine CXCL1 in Selected Tumors.

Korbecki J, Bosiacki M, Szatkowska I, Kupnicka P, Chlubek D, Baranowska-Bosiacka I Int J Mol Sci. 2024; 25(8).

PMID: 38673949 PMC: 11050300. DOI: 10.3390/ijms25084365.


References
1.
Bruno A, Focaccetti C, Pagani A, Imperatori A, Spagnoletti M, Rotolo N . The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia. 2013; 15(2):133-42. PMC: 3579316. DOI: 10.1593/neo.121758. View

2.
Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

3.
Hsu Y, Hung J, Chang W, Jian S, Lin Y, Pan Y . Hypoxic Lung-Cancer-Derived Extracellular Vesicle MicroRNA-103a Increases the Oncogenic Effects of Macrophages by Targeting PTEN. Mol Ther. 2018; 26(2):568-581. PMC: 5835028. DOI: 10.1016/j.ymthe.2017.11.016. View

4.
Huang Z, Qi G, Miller J, Zheng S . CD226: An Emerging Role in Immunologic Diseases. Front Cell Dev Biol. 2020; 8:564. PMC: 7396508. DOI: 10.3389/fcell.2020.00564. View

5.
Tsai M, Tsai Y, Chang W, Lin Y, Tsai P, Sheu C . Deducting MicroRNA-Mediated Changes Common in Bronchial Epithelial Cells of Asthma and Chronic Obstructive Pulmonary Disease-A Next-Generation Sequencing-Guided Bioinformatic Approach. Int J Mol Sci. 2019; 20(3). PMC: 6386886. DOI: 10.3390/ijms20030553. View